Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring

Laryngopharyngeal reflux (LPR) is the reflux of gastric acid through the esophagus that reaches laringopharyngeal area. The prevalence of LPR in the range 15–20%, and caused chronic rhinosinusitis (CRS). The incidence of LPR in patients with CRS has ranged between 37–72%. The prevalence of CRS 16,3%...

Full description

Bibliographic Details
Main Authors: Tantri Kurniawati, Teti Madiadipoera, Tonny Basriyadi Sarbini, Ongka M. Saifuddin
Format: Article
Language:English
Published: Universitas Padjajaran 2012-09-01
Series:Majalah Kedokteran Bandung
Subjects:
Online Access:http://journal.fk.unpad.ac.id/index.php/mkb/article/view/135
_version_ 1828169195288788992
author Tantri Kurniawati
Teti Madiadipoera
Tonny Basriyadi Sarbini
Ongka M. Saifuddin
author_facet Tantri Kurniawati
Teti Madiadipoera
Tonny Basriyadi Sarbini
Ongka M. Saifuddin
author_sort Tantri Kurniawati
collection DOAJ
description Laryngopharyngeal reflux (LPR) is the reflux of gastric acid through the esophagus that reaches laringopharyngeal area. The prevalence of LPR in the range 15–20%, and caused chronic rhinosinusitis (CRS). The incidence of LPR in patients with CRS has ranged between 37–72%. The prevalence of CRS 16,3% in adults and affecting quality of life. Omeprazole and lansoprazole are proton pump inhibitors (PPIs) for LPR’s therapy and also a therapy for CRS with LPR as the etiology. This research method was randomized clinical trial with open trial observation, conducted in June to December 2009. Twenty subjects with consecutive sampling method, divided into two groups (with simple randomization), the first group received omeprazole and the other lansoprazole. The subjects conducted complete physical otolaryngology examination, sino-nasal outcome test 20, reflux symptom index and reflux finding score with fiber optic rhinolaryngoscopy. These data was obtained before therapy, after 2 weeks and two months therapy, analyzed with Wilcoxon’s and Mann-Whitney’s test. There was no effectivity difference between omperazole and lansoprazole in reducing the level of severity of LPR (p>0.05), but quality of life improvement was better in lansoprazole than omeprazole group (p<0.05). In conclusion, lansoprazole is more effective than omeprazole in improvement of quality of life in patients with chronic rhinosinusitis caused by LPR
first_indexed 2024-04-12T02:47:13Z
format Article
id doaj.art-2ff1af1e74b34e8d8d55555a73040c18
institution Directory Open Access Journal
issn 0126-074X
2338-6223
language English
last_indexed 2024-04-12T02:47:13Z
publishDate 2012-09-01
publisher Universitas Padjajaran
record_format Article
series Majalah Kedokteran Bandung
spelling doaj.art-2ff1af1e74b34e8d8d55555a73040c182022-12-22T03:51:08ZengUniversitas PadjajaranMajalah Kedokteran Bandung0126-074X2338-62232012-09-0144313814610.15395/mkb.v44n3.135Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks LaringofaringTantri KurniawatiTeti MadiadipoeraTonny Basriyadi SarbiniOngka M. SaifuddinLaryngopharyngeal reflux (LPR) is the reflux of gastric acid through the esophagus that reaches laringopharyngeal area. The prevalence of LPR in the range 15–20%, and caused chronic rhinosinusitis (CRS). The incidence of LPR in patients with CRS has ranged between 37–72%. The prevalence of CRS 16,3% in adults and affecting quality of life. Omeprazole and lansoprazole are proton pump inhibitors (PPIs) for LPR’s therapy and also a therapy for CRS with LPR as the etiology. This research method was randomized clinical trial with open trial observation, conducted in June to December 2009. Twenty subjects with consecutive sampling method, divided into two groups (with simple randomization), the first group received omeprazole and the other lansoprazole. The subjects conducted complete physical otolaryngology examination, sino-nasal outcome test 20, reflux symptom index and reflux finding score with fiber optic rhinolaryngoscopy. These data was obtained before therapy, after 2 weeks and two months therapy, analyzed with Wilcoxon’s and Mann-Whitney’s test. There was no effectivity difference between omperazole and lansoprazole in reducing the level of severity of LPR (p>0.05), but quality of life improvement was better in lansoprazole than omeprazole group (p<0.05). In conclusion, lansoprazole is more effective than omeprazole in improvement of quality of life in patients with chronic rhinosinusitis caused by LPRhttp://journal.fk.unpad.ac.id/index.php/mkb/article/view/135Chronic rhinosinusitislansoprazolelaryngopharyngeal refluxomeprazolequality of life
spellingShingle Tantri Kurniawati
Teti Madiadipoera
Tonny Basriyadi Sarbini
Ongka M. Saifuddin
Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
Majalah Kedokteran Bandung
Chronic rhinosinusitis
lansoprazole
laryngopharyngeal reflux
omeprazole
quality of life
title Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
title_full Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
title_fullStr Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
title_full_unstemmed Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
title_short Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring
title_sort perbandingan efektivitas antara omeprazol dan lansoprazol terhadap perbaikan kualitas hidup penderita rinosinusitis kronik akibat refluks laringofaring
topic Chronic rhinosinusitis
lansoprazole
laryngopharyngeal reflux
omeprazole
quality of life
url http://journal.fk.unpad.ac.id/index.php/mkb/article/view/135
work_keys_str_mv AT tantrikurniawati perbandinganefektivitasantaraomeprazoldanlansoprazolterhadapperbaikankualitashiduppenderitarinosinusitiskronikakibatreflukslaringofaring
AT tetimadiadipoera perbandinganefektivitasantaraomeprazoldanlansoprazolterhadapperbaikankualitashiduppenderitarinosinusitiskronikakibatreflukslaringofaring
AT tonnybasriyadisarbini perbandinganefektivitasantaraomeprazoldanlansoprazolterhadapperbaikankualitashiduppenderitarinosinusitiskronikakibatreflukslaringofaring
AT ongkamsaifuddin perbandinganefektivitasantaraomeprazoldanlansoprazolterhadapperbaikankualitashiduppenderitarinosinusitiskronikakibatreflukslaringofaring